March 20, 2026

In a decisive move, the U.S. District Court in Boston has issued a preliminary injunction against Health Secretary Robert F. Kennedy Jr. and the Department of Health and Human Services (HHS), putting a temporary stop to recent changes in the vaccination schedule proposed by the government. This ruling arrives amid growing concerns from several health organizations, including a lawsuit led by the American Academy of Pediatrics, challenging the procedural integrity and scientific basis of the changes.
The core of the controversy lies in the changes made to the CDC’s Advisory Committee on Immunization Practices (ACIP), where Kennedy replaced all existing members with new appointees last June. These appointees, many of whom have expressed skepticism about vaccines, had recommended alterations to the vaccination schedule, including not vaccinating all newborns against hepatitis B. The court’s decision underscores a significant breach of the Administrative Procedures Act (APA), which mandates that federal agency actions be grounded in fact and follow defined procedures.
Judge Brian Murphy’s ruling criticizes the government’s actions as a "procedural failure" that not only ignored the established scientific advisory process but also potentially jeopardized public health by sidelining expert recommendations. The injunction also halts the participation of the 13 new members appointed by Kennedy, pending a more thorough review.
The legal battle appears set to escalate as the government has indicated plans to appeal the ruling. This sets the stage for a potentially protracted legal struggle, with implications that may reach as far as the Supreme Court. Observers are closely watching this case as it develops, given its potential to significantly influence public health policy and the balance of power between the executive branch and judicial oversight.
Meanwhile, the immediate effect of the court’s decision is the postponement of an ACIP meeting, which had been scheduled to discuss further changes to vaccination policies. Public health advocates and legal experts alike are parsing Judge Murphy’s scathing remarks on the importance of adhering to scientific and procedural norms.
The administration’s approach to vaccine policy under Kennedy’s leadership has been fraught with controversy, reflecting deeper political and ideological divides over public health management. As the case progresses, it will undoubtedly continue to spark debate over the role of science in government policy and the legal limits of executive authority in public health matters.
For now, the preliminary injunction serves as a critical check on hastily made health policy changes, reaffirming the role of law and procedure in governing public health actions.